X-101886725-C-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 0P and 2B. BP4_Moderate
The NM_001394560.1(ZMAT1):c.683G>T(p.Ser228Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000255 in 1,176,357 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 2 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 12/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001394560.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZMAT1 | NM_001394560.1 | c.683G>T | p.Ser228Ile | missense_variant | 5/6 | ENST00000651725.2 | NP_001381489.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZMAT1 | ENST00000651725.2 | c.683G>T | p.Ser228Ile | missense_variant | 5/6 | NM_001394560.1 | ENSP00000498446 | A2 |
Frequencies
GnomAD3 genomes AF: 0.00000897 AC: 1AN: 111499Hom.: 0 Cov.: 23 AF XY: 0.0000296 AC XY: 1AN XY: 33773
GnomAD4 exome AF: 0.00000188 AC: 2AN: 1064858Hom.: 0 Cov.: 24 AF XY: 0.00000299 AC XY: 1AN XY: 333970
GnomAD4 genome AF: 0.00000897 AC: 1AN: 111499Hom.: 0 Cov.: 23 AF XY: 0.0000296 AC XY: 1AN XY: 33773
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 30, 2023 | The c.512G>T (p.S171I) alteration is located in exon 6 (coding exon 5) of the ZMAT1 gene. This alteration results from a G to T substitution at nucleotide position 512, causing the serine (S) at amino acid position 171 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at